GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 18.36
-0.59 (-3.11%)
At close: Sep 11, 2025
GemPharmatech Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
Net Income | 104.39 | 109.82 | 158.91 | 164.67 | 124.93 | 76.43 | Upgrade |
Depreciation & Amortization | 84.23 | 83.74 | 53.73 | 39.07 | 28.81 | 16.83 | Upgrade |
Other Amortization | 14.48 | 13.17 | 8.55 | 7.93 | 5.83 | 1.52 | Upgrade |
Loss (Gain) From Sale of Assets | 0.01 | -0.01 | 0.02 | 0.1 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | - | - | 14.08 | 9.24 | Upgrade |
Loss (Gain) From Sale of Investments | -2.97 | -10.35 | -14.24 | -9.44 | -11.43 | -7.08 | Upgrade |
Provision & Write-off of Bad Debts | 4.23 | 3.29 | 9.09 | 8.53 | 6.96 | 3.24 | Upgrade |
Other Operating Activities | 16.15 | 18.93 | 20.14 | 11.48 | 1.21 | 1.39 | Upgrade |
Change in Accounts Receivable | -91.33 | -91.33 | -87.52 | -81.09 | -73.31 | -37.98 | Upgrade |
Change in Inventory | -8.69 | -7.1 | 2.38 | -19.39 | -11.91 | -5.64 | Upgrade |
Change in Accounts Payable | 21.81 | -27.48 | -23.85 | -7.7 | 23.89 | 41.84 | Upgrade |
Change in Other Net Operating Assets | 4.89 | 2.98 | 4.66 | 0.67 | 3.07 | 27.46 | Upgrade |
Operating Cash Flow | 149.14 | 90.31 | 116.57 | 105.98 | 113.31 | 129.79 | Upgrade |
Operating Cash Flow Growth | 218.73% | -22.52% | 9.99% | -6.47% | -12.69% | 99.29% | Upgrade |
Capital Expenditures | -111.73 | -113.68 | -205.9 | -190.31 | -89.07 | -167.07 | Upgrade |
Sale of Property, Plant & Equipment | 0.01 | - | 0.11 | 0.11 | - | - | Upgrade |
Investment in Securities | -333.28 | 259.21 | 176.24 | -814.72 | -275.19 | - | Upgrade |
Other Investing Activities | 7.73 | 13.36 | 10.94 | 10.26 | 10.53 | 33.96 | Upgrade |
Investing Cash Flow | -437.27 | 158.89 | -18.61 | -994.66 | -353.73 | -133.11 | Upgrade |
Short-Term Debt Issued | - | 97.95 | 86 | 11.99 | - | - | Upgrade |
Long-Term Debt Issued | - | - | - | - | 25 | 22 | Upgrade |
Total Debt Issued | 250.45 | 97.95 | 86 | 11.99 | 25 | 22 | Upgrade |
Short-Term Debt Repaid | - | -86 | -21.99 | -25 | - | - | Upgrade |
Long-Term Debt Repaid | - | -8.11 | -6.42 | -2.08 | -10.71 | -28 | Upgrade |
Total Debt Repaid | -129.5 | -94.11 | -28.42 | -27.08 | -10.71 | -28 | Upgrade |
Net Debt Issued (Repaid) | 120.95 | 3.84 | 57.58 | -15.09 | 14.29 | -6 | Upgrade |
Issuance of Common Stock | 11.25 | - | - | 1,044 | - | 313 | Upgrade |
Repurchase of Common Stock | -13.92 | -32.67 | - | - | - | - | Upgrade |
Common Dividends Paid | -80.89 | -80.11 | -17.87 | -0.28 | -0.68 | -0.67 | Upgrade |
Other Financing Activities | - | - | -0.43 | -14.22 | -3.39 | - | Upgrade |
Financing Cash Flow | 37.39 | -108.94 | 39.29 | 1,014 | 10.23 | 306.33 | Upgrade |
Foreign Exchange Rate Adjustments | 2.45 | 0.96 | 1.15 | 2.63 | -0.46 | -0.74 | Upgrade |
Net Cash Flow | -248.28 | 141.22 | 138.4 | 128.08 | -230.65 | 302.27 | Upgrade |
Free Cash Flow | 37.41 | -23.36 | -89.33 | -84.33 | 24.24 | -37.28 | Upgrade |
Free Cash Flow Margin | 5.19% | -3.40% | -14.36% | -16.33% | 6.16% | -14.23% | Upgrade |
Free Cash Flow Per Share | 0.09 | -0.06 | -0.22 | -0.21 | 0.07 | -0.10 | Upgrade |
Cash Income Tax Paid | 27.58 | 40.59 | 3.44 | 3.17 | 27.32 | 18.82 | Upgrade |
Levered Free Cash Flow | -32.87 | -57.81 | -75.74 | -115.52 | -35.41 | -69.24 | Upgrade |
Unlevered Free Cash Flow | -29.78 | -55.12 | -74.01 | -115.21 | -34.95 | -68.79 | Upgrade |
Change in Working Capital | -71.38 | -128.27 | -119.63 | -116.35 | -57.07 | 28.21 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.